In line with the market needs of our marketing partners, we offer
FULL MANUFACTURING SERVICES FOR FINISHED DOSAGE FORMS OF PHARMACEUTICALS
that are customised and based upon our own developments
Neuraxpharm has a strong focus on R&D and the generation of intellectual property using our comprehensive in-house capabilities. We have a long history of successfully developing dossiers of generic and specialised pharmaceuticals that meet the latest high regulatory standards.
are available to be licensed from Lesvi, including the supply of finished dosage forms with customised artwork as per specific market needs
OUR STRONG R&D
FOCUS WITH IN-HOUSE CAPABILITIES MAKES
US STAND OUT FROM
We see our clients as true marketing partners and offer a complete service for every aspect of the products we develop.
The primary focus of our developments is in full compliance with the requirements of the EU market. This focus on quality has allowed our partners to register and market their products worldwide.
We offer a range of choices in dosage forms and technologies for each requirements.
SOLID FORMS: · Dry granulation · Wet granulation · Direct mixes · Production of tablets, coated tablets and capsules · Production of effervescent tablet
STERILE LIQUID FORMS: · Ear and eye single doses
NON-STERILE LIQUID FORMS: · Suspensions
OUTER PACKAGING: · PVC, PVDC, Aclar® · Aluminium blisters · Effervescent tablets in tubes · Bottles of solutions · Extemporaneous suspensions · Single doses in aluminium "flow-packs"
CONTRACT MANUFACTURING SERVICES
A capacity of over 30 million packs a year
200 people distributed among Quality Control, Contract Manufacturing, Quality Assurance, Engineering, Logistics, Safety and Environment and Production.
LESVI’S ACTIVITY FOCUSES ON THE DEVELOPMENT AND MANUFACTURING OF ORAL SOLID AND STERILE AND NON-STERILE LIQUID FORMS
Our highly flexible approach and extensive experience in the development and manufacturing of finished dosage forms have enabled us to become reliable partners for both large national and international third-party laboratories